Stay updated with breaking news from Wilson Bryan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hundreds of clinics pushing unproven stem cell procedures caught a big break from the U.S. government in 2017: They would have three years to show that their questionable treatments were safe and worked before regulators started cracking down. But when the Food and Drug Administration’s grace period expired in late May — extended six months…
Editor’s note: This story is part of a series on the trends that will shape the industry in 2021. You can find all the articles on our trendline. Few government agencies were as front and center in the public eye last year as the Food and Drug Administration, which came under immense pressure to authorize unproven drugs as the world grappled with the pandemic and conducted high-stakes reviews of two coronavirus vaccines. As COVID-19 cases continue to soar in the U.S., most of those pressures haven't gone away. But the inauguration next week of Joseph Biden as president will almost certainly...